Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 153

1.

The influence of testosterone suppression and recovery on sexual function in men with prostate cancer: observations from a prospective study in men undergoing intermittent androgen suppression.

Ng E, Woo HH, Turner S, Leong E, Jackson M, Spry N.

J Urol. 2012 Jun;187(6):2162-6. doi: 10.1016/j.juro.2012.01.080. Epub 2012 Apr 12.

PMID:
22503022
[PubMed - indexed for MEDLINE]
2.

Intermittent androgen castration: a biological reality during intermittent treatment in metastatic prostate cancer?

Mottet N, Lucas C, Sene E, Avances C, Maubach L, Wolff JM.

Urol Int. 2005;75(3):204-8.

PMID:
16215305
[PubMed - indexed for MEDLINE]
3.

A pilot study of intermittent androgen ablation in advanced prostate cancer in Japanese men.

Egawa S, Takashima R, Matsumoto K, Mizoguchi H, Kuwao S, Baba S.

Jpn J Clin Oncol. 2000 Jan;30(1):21-6.

PMID:
10770564
[PubMed - indexed for MEDLINE]
Free Article
4.

Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate.

Brufsky A, Fontaine-Rothe P, Berlane K, Rieker P, Jiroutek M, Kaplan I, Kaufman D, Kantoff P.

Urology. 1997 Jun;49(6):913-20.

PMID:
9187700
[PubMed - indexed for MEDLINE]
5.

Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer.

Spry NA, Kristjanson L, Hooton B, Hayden L, Neerhut G, Gurney H, Corica T, Korbel E, Weinstein S, McCaul K.

Eur J Cancer. 2006 May;42(8):1083-92. Epub 2006 May 2.

PMID:
16632343
[PubMed - indexed for MEDLINE]
6.
7.

Intermittent hormonal therapy in the treatment of metastatic prostate cancer: a randomized trial.

Mottet N, Van Damme J, Loulidi S, Russel C, Leitenberger A, Wolff JM; TAP22 Investigators Group.

BJU Int. 2012 Nov;110(9):1262-9. doi: 10.1111/j.1464-410X.2012.11120.x. Epub 2012 Apr 13.

PMID:
22502816
[PubMed - indexed for MEDLINE]
8.

Intermittent androgen suppression--ready for prime time?

Ischia J, Goldenberg SL.

J Urol. 2012 Jun;187(6):1956-7. doi: 10.1016/j.juro.2012.03.034. Epub 2012 Apr 11. No abstract available.

PMID:
22503023
[PubMed - indexed for MEDLINE]
9.

Intermittent androgen suppression for locally advanced and metastatic prostate cancer: preliminary report of a prospective multicenter study.

Sato N, Akakura K, Isaka S, Nakatsu H, Tanaka M, Ito H, Masai M; Chiba Prostate Study Group.

Urology. 2004 Aug;64(2):341-5.

PMID:
15302491
[PubMed - indexed for MEDLINE]
10.

The FinnProstate Study VII: intermittent versus continuous androgen deprivation in patients with advanced prostate cancer.

Salonen AJ, Taari K, Ala-Opas M, Viitanen J, Lundstedt S, Tammela TL; FinnProstate Group.

J Urol. 2012 Jun;187(6):2074-81. doi: 10.1016/j.juro.2012.01.122. Epub 2012 Apr 11.

PMID:
22498230
[PubMed - indexed for MEDLINE]
11.

Intermittent complete androgen blockade in metastatic prostate cancer.

Rambeaud JJ.

Eur Urol. 1999;35 Suppl 1:32-6. Review.

PMID:
10081701
[PubMed - indexed for MEDLINE]
12.

Finnish multicenter study comparing intermittent to continuous androgen deprivation for advanced prostate cancer: interim analysis of prognostic markers affecting initial response to androgen deprivation.

Salonen AJ, Viitanen J, Lundstedt S, Ala-Opas M, Taari K, Tammela TL; FinnProstate Group.

J Urol. 2008 Sep;180(3):915-9; discussion 919-20. doi: 10.1016/j.juro.2008.05.009. Epub 2008 Jul 17.

PMID:
18635219
[PubMed - indexed for MEDLINE]
13.

Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer.

DiBlasio CJ, Malcolm JB, Derweesh IH, Womack JH, Kincade MC, Mancini JG, Ogles ML, Lamar KD, Patterson AL, Wake RW.

BJU Int. 2008 Jul;102(1):39-43. doi: 10.1111/j.1464-410X.2008.07505.x. Epub 2008 Feb 21.

PMID:
18294309
[PubMed - indexed for MEDLINE]
14.

Long-term effects of intermittent androgen suppression on testosterone recovery and bone mineral density: results of a 33-month observational study.

Spry NA, Galvão DA, Davies R, La Bianca S, Joseph D, Davidson A, Prince R.

BJU Int. 2009 Sep;104(6):806-12. doi: 10.1111/j.1464-410X.2009.08458.x. Epub 2009 Mar 5.

PMID:
19281463
[PubMed - indexed for MEDLINE]
16.

Long-term effects of intermittent androgen suppression therapy on lean and fat mass: a 33-month prospective study.

Spry NA, Taaffe DR, England PJ, Judge JS, Stephens DA, Peddle-McIntyre C, Baker MK, Newton RU, Galvão DA.

Prostate Cancer Prostatic Dis. 2013 Mar;16(1):67-72. doi: 10.1038/pcan.2012.33. Epub 2012 Aug 21.

PMID:
22907511
[PubMed - indexed for MEDLINE]
17.

Kinetics of serum androgen normalization and factors associated with testosterone reserve after limited androgen deprivation therapy for nonmetastatic prostate cancer.

Gulley JL, Aragon-Ching JB, Steinberg SM, Hussain MH, Sartor O, Higano CS, Petrylak DP, Chatta GS, Arlen PM, Figg WD, Dahut WL.

J Urol. 2008 Oct;180(4):1432-7; discussion 1437. doi: 10.1016/j.juro.2008.06.017. Epub 2008 Aug 16.

PMID:
18710748
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

New treatment paradigm for prostate cancer: abarelix initiation therapy for immediate testosterone suppression followed by a luteinizing hormone-releasing hormone agonist.

Garnick MB, Mottet N.

BJU Int. 2012 Aug;110(4):499-504. doi: 10.1111/j.1464-410X.2011.10708.x. Epub 2011 Nov 16.

PMID:
22093775
[PubMed - indexed for MEDLINE]
19.

Determining dosing intervals for luteinizing hormone releasing hormone agonists based on serum testosterone levels: a prospective study.

Pathak AS, Pacificar JS, Shapiro CE, Williams SG.

J Urol. 2007 Jun;177(6):2132-5; discussion 2135.

PMID:
17509298
[PubMed - indexed for MEDLINE]
20.

Advanced prostate cancer treated with intermittent or continuous androgen deprivation in the randomised FinnProstate Study VII: quality of life and adverse effects.

Salonen AJ, Taari K, Ala-Opas M, Viitanen J, Lundstedt S, Tammela TL; FinnProstate Group.

Eur Urol. 2013 Jan;63(1):111-20. doi: 10.1016/j.eururo.2012.07.040. Epub 2012 Jul 27.

PMID:
22857983
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk